Page 6 - Negotiation Program News Today

Industry is using the same old playbook

In recent months, six different lawsuits have been filed challenging the Inflation Reduction Act (IRA)'s Drug Price Negotiation Program (the "Program"), with a flurry of activity likely in the coming months...

The first six months of the 118th Congress have been an active stretch for the House and Senate committees with jurisdiction over health care issues. Legislative activity has spanned the health...

Almost 11 months after President Biden signed the Medicare Drug Price Negotiation Program (“Negotiation Program”) into law, the Centers for Medicare and Medicaid Services (CMS) has...

Congress is taking a closer look at business practices in the health care sector and considering bipartisan reforms in light of increasing consolidation and its perceived affects on...

On June 30, 2023, the Centers for Medicare & Medicaid Services ("CMS") issued its final guidance memorandum1 (the "Final Guidance") on the implementation of the Inflation Reduction Act ("IRA") Medicare Drug Price Negotiation Program for the Initial Price Applicability Year of 2026.

Looming large in Washington right now is the upcoming debt limit debate. With the United States expected this summer to hit the statutory cap on the amount of money the government can borrow...

The Centers for Medicare & Medicaid Services (CMS) recently issued initial guidance on how the agency expects the Medicare Drug Price Negotiation Program (the “Negotiation Program”) to...

Centers for Medicare and Medicaid Services CMS issued initial program guidance related to implementation of the Medicare Drug Price Negotiation Program. CMS requested public comments on selected portions of the guidance by April 14, 2023.

On March 15, 2023, the Centers for Medicare & Medicaid Services (CMS) issued an initial guidance memorandum on the Medicare Drug Price Negotiation Program (Negotiation Program) created...